(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of ERCC1 mRNA CTD PMID:17971868 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ERCC1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1315922 6480464 [epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9 more ... CTD PMID:23717041 (-)-quinic acid multiple interactions ISO RGD:1315921 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of ERCC1 mRNA CTD PMID:21751221 1,2-dimethylhydrazine increases expression ISO RGD:1315922 6480464 1, 2-Dimethylhydrazine results in increased expression of ERCC1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1315922 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ERCC1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1315921 6480464 decitabine inhibits the reaction [Estradiol results in decreased expression of ERCC1 mRNA] CTD PMID:22082530 17beta-estradiol decreases expression ISO RGD:1315921 6480464 Estradiol results in decreased expression of ERCC1 mRNA CTD PMID:22082530 1H-pyrazole increases expression ISO RGD:1315922 6480464 pyrazole results in increased expression of ERCC1 mRNA CTD PMID:17945193 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:28712647 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1315922 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1315921 6480464 2 more ... CTD PMID:26808241 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1315922 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ERCC1 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ERCC1 promoter] CTD PMID:17942748 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ERCC1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1315922 6480464 Tetrachlorodibenzodioxin affects the expression of ERCC1 mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ERCC1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1315921 6480464 Lactic Acid results in decreased expression of ERCC1 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1315922 6480464 tetrabromobisphenol A results in increased expression of ERCC1 mRNA CTD PMID:25172293 3-aminobenzamide multiple interactions ISO RGD:1315921 6480464 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA], 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 protein] CTD PMID:22228707 3-aminobenzamide multiple interactions EXP 6480464 3-aminobenzamide inhibits the reaction [Streptozocin results in increased expression of ERCC1 mRNA] CTD PMID:22228707 3-aminobenzamide decreases expression ISO RGD:1315921 6480464 3-aminobenzamide results in decreased expression of ERCC1 mRNA, 3-aminobenzamide results in decreased expression of ERCC1 protein CTD PMID:22228707 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of ERCC1 mRNA CTD PMID:21346803 4-hydroxynon-2-enal decreases expression ISO RGD:1315922 6480464 4-hydroxy-2-nonenal results in decreased expression of ERCC1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1315921 6480464 Fenretinide results in increased expression of ERCC1 protein CTD PMID:15059897 4-hydroxyphenyl retinamide increases expression ISO RGD:1315922 6480464 Fenretinide results in increased expression of ERCC1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1315921 6480464 Decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of ERCC1 mRNA] more ... CTD PMID:22082530 , PMID:22112500 5-aza-2'-deoxycytidine decreases expression ISO RGD:1315921 6480464 Decitabine results in decreased expression of ERCC1 mRNA CTD PMID:22082530 5-fluorouracil multiple interactions ISO RGD:1315921 6480464 [Cisplatin co-treated with Fluorouracil] results in decreased expression of ERCC1 mRNA more ... CTD PMID:15173087 more ... 5-fluorouracil decreases expression ISO RGD:1315921 6480464 Fluorouracil results in decreased expression of ERCC1 mRNA CTD PMID:17016597 5-formyltetrahydrofolic acid multiple interactions ISO RGD:1315921 6480464 ERCC1 gene SNP affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] CTD PMID:17401013 7,12-dimethyltetraphene decreases expression ISO RGD:1315922 6480464 9 more ... CTD PMID:23717041 7,12-dimethyltetraphene multiple interactions ISO RGD:1315922 6480464 [epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9 more ... CTD PMID:23717041 acrolein multiple interactions ISO RGD:1315921 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ERCC1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ERCC1 mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO RGD:1315921 6480464 Aflatoxin B1 results in increased expression of ERCC1 mRNA CTD PMID:22100608 aldehydo-D-glucose multiple interactions ISO RGD:1315921 6480464 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA] more ... CTD PMID:22228707 aldehydo-D-glucose increases expression ISO RGD:1315921 6480464 Glucose results in increased expression of ERCC1 mRNA, Glucose results in increased expression of ERCC1 protein CTD PMID:22228707 alpha-pinene multiple interactions ISO RGD:1315921 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ERCC1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ERCC1 mRNA CTD PMID:32699268 amphibole asbestos increases expression ISO RGD:1315921 6480464 Asbestos, Amphibole results in increased expression of ERCC1 protein CTD PMID:20855422 arsane decreases expression ISO RGD:1315921 6480464 Arsenic results in decreased expression of ERCC1 mRNA, Arsenic results in decreased expression of ERCC1 protein CTD PMID:12569548 , PMID:16882524 arsane multiple interactions ISO RGD:1315921 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of ERCC1 mRNA CTD PMID:33736254 arsane affects expression ISO RGD:1315921 6480464 Arsenic affects the expression of ERCC1 mRNA CTD PMID:33736254 arsane increases expression ISO RGD:1315921 6480464 Arsenic results in increased expression of ERCC1 mRNA CTD PMID:19661343 arsenic atom increases expression ISO RGD:1315921 6480464 Arsenic results in increased expression of ERCC1 mRNA CTD PMID:19661343 arsenic atom affects expression ISO RGD:1315921 6480464 Arsenic affects the expression of ERCC1 mRNA CTD PMID:33736254 arsenic atom multiple interactions ISO RGD:1315921 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of ERCC1 mRNA CTD PMID:33736254 arsenic atom decreases expression ISO RGD:1315921 6480464 Arsenic results in decreased expression of ERCC1 mRNA, Arsenic results in decreased expression of ERCC1 protein CTD PMID:12569548 , PMID:16882524 azathioprine increases expression ISO RGD:1315921 6480464 Azathioprine results in increased expression of ERCC1 mRNA CTD PMID:22623647 benzene affects expression ISO RGD:1315921 6480464 Benzene affects the expression of ERCC1 mRNA CTD PMID:16188086 benzo[a]pyrene affects expression ISO RGD:1315921 6480464 Benzo(a)pyrene affects the expression of ERCC1 mRNA CTD PMID:20624995 benzo[a]pyrene decreases expression ISO RGD:1315921 6480464 Benzo(a)pyrene results in decreased expression of ERCC1 protein CTD PMID:30020114 benzo[a]pyrene multiple interactions ISO RGD:1315922 6480464 Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of ERCC1 mRNA] CTD PMID:30020114 benzo[a]pyrene decreases expression ISO RGD:1315922 6480464 Benzo(a)pyrene results in decreased expression of ERCC1 mRNA CTD PMID:30020114 benzo[a]pyrene multiple interactions ISO RGD:1315921 6480464 [Folic Acid co-treated with Benzo(a)pyrene] results in increased expression of ERCC1 mRNA, Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of ERCC1 protein] CTD PMID:30020114 benzo[a]pyrene increases expression ISO RGD:1315922 6480464 Benzo(a)pyrene results in increased expression of ERCC1 mRNA CTD PMID:22228805 , PMID:22641617 benzo[a]pyrene affects response to substance ISO RGD:1315921 6480464 ERCC1 protein affects the susceptibility to Benzo(a)pyrene CTD PMID:22382310 benzo[a]pyrene increases expression ISO RGD:1315921 6480464 Benzo(a)pyrene results in increased expression of ERCC1 mRNA, Benzo(a)pyrene results in increased expression of ERCC1 protein CTD PMID:19748547 , PMID:21632981 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1315921 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I affects response to substance ISO RGD:1315921 6480464 ERCC1 gene SNP affects the susceptibility to 7 more ... CTD PMID:30453383 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ERCC1 mRNA CTD PMID:25181051 cadmium dichloride decreases expression ISO RGD:1315922 6480464 Cadmium Chloride results in decreased expression of ERCC1 mRNA CTD PMID:15501611 cadmium dichloride increases expression ISO RGD:1315921 6480464 Cadmium Chloride results in increased expression of ERCC1 protein CTD PMID:26220685 cadmium dichloride decreases expression ISO RGD:1315921 6480464 Cadmium Chloride results in decreased expression of ERCC1 mRNA, Cadmium Chloride results in decreased expression of ERCC1 protein CTD PMID:22112500 , PMID:26472689 cadmium dichloride multiple interactions ISO RGD:1315921 6480464 [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in decreased expression of ERCC1 mRNA more ... CTD PMID:22112500 cadmium dichloride increases methylation ISO RGD:1315921 6480464 Cadmium Chloride results in increased methylation of ERCC1 promoter CTD PMID:22112500 cadmium dichloride increases expression ISO RGD:1315922 6480464 Cadmium Chloride results in increased expression of ERCC1 mRNA CTD PMID:11958953 cadmium dichloride multiple interactions ISO RGD:1315922 6480464 MT1 affects the reaction [Cadmium Chloride results in increased expression of ERCC1 mRNA], MT2 affects the reaction [Cadmium Chloride results in increased expression of ERCC1 mRNA] CTD PMID:11958953 camptothecin multiple interactions ISO RGD:1315921 6480464 ERCC1 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]] CTD PMID:21227924 camptothecin decreases expression ISO RGD:1315921 6480464 Camptothecin results in decreased expression of ERCC1 mRNA CTD PMID:24792648 carbon nanotube increases expression ISO RGD:1315922 6480464 Nanotubes, Carbon results in increased expression of ERCC1 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:1315922 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ERCC1 gene CTD PMID:20938992 cisplatin affects expression ISO RGD:1315921 6480464 Cisplatin affects the expression of ERCC1 mRNA, Cisplatin affects the expression of ERCC1 protein CTD PMID:21750216 , PMID:24799992 cisplatin multiple interactions EXP 6480464 Lovastatin promotes the reaction [Cisplatin results in increased expression of ERCC1 mRNA] CTD PMID:26739623 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ERCC1 mRNA CTD PMID:26739623 cisplatin increases expression ISO RGD:1315921 6480464 Cisplatin results in increased expression of ERCC1 mRNA, Cisplatin results in increased expression of ERCC1 protein CTD PMID:21165580 more ... cisplatin decreases response to substance ISO RGD:1315922 6480464 ERCC1 results in decreased susceptibility to Cisplatin CTD PMID:21722328 cisplatin increases response to substance ISO RGD:1315921 6480464 ERCC1 protein results in increased susceptibility to Cisplatin CTD PMID:21076943 cisplatin decreases response to substance ISO RGD:1315921 6480464 ERCC1 protein results in decreased susceptibility to Cisplatin, ERCC1 results in decreased susceptibility to Cisplatin CTD PMID:21093896 more ... cisplatin multiple interactions ISO RGD:1315921 6480464 [Cisplatin co-treated with Fluorouracil] results in decreased expression of ERCC1 mRNA more ... CTD PMID:15173087 more ... cobalt atom multiple interactions ISO RGD:1315922 6480464 [Cobalt co-treated with Organometallic Compounds] results in increased expression of ERCC1 mRNA CTD PMID:22147119 cobalt atom increases expression ISO RGD:1315922 6480464 Cobalt results in increased expression of ERCC1 mRNA CTD PMID:22147119 cobalt dichloride decreases expression ISO RGD:1315921 6480464 cobaltous chloride results in decreased expression of ERCC1 mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ERCC1 mRNA CTD PMID:24386269 copper(II) sulfate increases expression ISO RGD:1315921 6480464 Copper Sulfate results in increased expression of ERCC1 mRNA CTD PMID:19549813 curcumin multiple interactions ISO RGD:1315921 6480464 [Curcumin results in decreased expression of ERCC1 protein] which results in increased susceptibility to Cisplatin more ... CTD PMID:21493726 , PMID:22228707 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Streptozocin results in increased expression of ERCC1 mRNA] CTD PMID:22228707 curcumin decreases expression ISO RGD:1315921 6480464 Curcumin results in decreased expression of ERCC1 mRNA, Curcumin results in decreased expression of ERCC1 protein CTD PMID:17596214 more ... cyclophosphamide affects expression EXP 6480464 Cyclophosphamide affects the expression of ERCC1 mRNA CTD PMID:11906922 cyclosporin A increases expression ISO RGD:1315921 6480464 Cyclosporine results in increased expression of ERCC1 mRNA CTD PMID:20106945 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA CTD PMID:29038839 D-glucose increases expression ISO RGD:1315921 6480464 Glucose results in increased expression of ERCC1 mRNA, Glucose results in increased expression of ERCC1 protein CTD PMID:22228707 D-glucose multiple interactions ISO RGD:1315921 6480464 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA] more ... CTD PMID:22228707 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ERCC1 mRNA CTD PMID:33729688 disodium selenite increases expression ISO RGD:1315921 6480464 Sodium Selenite results in increased expression of ERCC1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1315921 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERCC1 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1315922 6480464 Doxorubicin results in increased expression of ERCC1 mRNA CTD PMID:22712078 elemental selenium increases expression ISO RGD:1315921 6480464 Selenium results in increased expression of ERCC1 mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ERCC1 mRNA CTD PMID:29391264 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA CTD PMID:29038839 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ERCC1 mRNA CTD PMID:34547370 finasteride increases expression EXP 6480464 Finasteride results in increased expression of ERCC1 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ERCC1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1315922 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ERCC1 gene, Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of ERCC1 mRNA] CTD PMID:20938992 , PMID:30020114 folic acid multiple interactions ISO RGD:1315921 6480464 [Folic Acid co-treated with Benzo(a)pyrene] results in increased expression of ERCC1 mRNA, Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of ERCC1 protein] CTD PMID:30020114 fonofos affects response to substance ISO RGD:1315921 6480464 ERCC1 polymorphism affects the susceptibility to Fonofos CTD PMID:22102698 furan increases expression EXP 6480464 furan results in increased expression of ERCC1 mRNA CTD PMID:22079235 gefitinib multiple interactions ISO RGD:1315921 6480464 ERCC1 gene polymorphism affects the susceptibility to [gefitinib co-treated with Cisplatin] CTD PMID:21264830 gefitinib affects response to substance ISO RGD:1315921 6480464 ERCC1 gene polymorphism affects the susceptibility to gefitinib CTD PMID:21264830 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ERCC1 mRNA CTD PMID:33387578 glucose increases expression ISO RGD:1315921 6480464 Glucose results in increased expression of ERCC1 mRNA, Glucose results in increased expression of ERCC1 protein CTD PMID:22228707 glucose multiple interactions ISO RGD:1315921 6480464 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA] more ... CTD PMID:22228707 hexadecanoic acid multiple interactions ISO RGD:1315921 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of ERCC1 mRNA CTD PMID:33736254 hydrogen peroxide multiple interactions ISO RGD:1315921 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of ERCC1 mRNA CTD PMID:21751221 irinotecan decreases expression ISO RGD:1315921 6480464 Irinotecan results in decreased expression of ERCC1 protein CTD PMID:11593056 isotretinoin decreases expression ISO RGD:1315921 6480464 Isotretinoin results in decreased expression of ERCC1 mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:1315922 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ERCC1 gene CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of ERCC1 mRNA CTD PMID:33862172 lead nitrate multiple interactions ISO RGD:1315922 6480464 lead nitrate affects the reaction [ERCC1 affects the expression of MT1 mRNA], lead nitrate affects the reaction [ERCC1 affects the expression of MT2 mRNA] CTD PMID:11891201 lipopolysaccharide multiple interactions ISO RGD:1315921 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of ERCC1 mRNA CTD PMID:22777745 lithium chloride increases expression ISO RGD:1315921 6480464 Lithium Chloride results in increased expression of ERCC1 mRNA CTD PMID:15711924 lovastatin multiple interactions EXP 6480464 Lovastatin promotes the reaction [Cisplatin results in increased expression of ERCC1 mRNA] CTD PMID:26739623 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of ERCC1 mRNA CTD PMID:26739623 MeIQx decreases expression ISO RGD:1315921 6480464 2-amino-3 more ... CTD PMID:22100608 melatonin increases expression ISO RGD:1315921 6480464 Melatonin results in increased expression of ERCC1 protein CTD PMID:24799992 methylseleninic acid increases expression ISO RGD:1315921 6480464 methylselenic acid results in increased expression of ERCC1 mRNA CTD PMID:12517777 microcystin RR decreases expression ISO RGD:1315921 6480464 microcystin RR results in decreased expression of ERCC1 protein CTD PMID:19111056 myristicin decreases expression ISO RGD:1315921 6480464 myristicin results in decreased expression of ERCC1 mRNA CTD PMID:24792648 N-acetyl-L-cysteine multiple interactions ISO RGD:1315921 6480464 Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of ERCC1 mRNA] CTD PMID:33971260 oxaliplatin multiple interactions ISO RGD:1315921 6480464 ERCC1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with oxaliplatin], ERCC1 gene SNP affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] CTD PMID:15213713 more ... oxaliplatin increases expression ISO RGD:1315921 6480464 oxaliplatin results in increased expression of ERCC1 mRNA CTD PMID:16773204 oxaliplatin affects response to substance ISO RGD:1315921 6480464 ERCC1 gene polymorphism affects the susceptibility to oxaliplatin, ERCC1 protein affects the susceptibility to oxaliplatin CTD PMID:15041737 more ... ozone multiple interactions ISO RGD:1315921 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ERCC1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1315922 6480464 Acetaminophen affects the expression of ERCC1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ERCC1 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:1315921 6480464 Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of ERCC1 mRNA] CTD PMID:33971260 paracetamol increases expression ISO RGD:1315921 6480464 Acetaminophen results in increased expression of ERCC1 mRNA CTD PMID:33971260 paraquat affects splicing ISO RGD:1315921 6480464 Paraquat affects the splicing of ERCC1 mRNA CTD PMID:23613995 PD 0325901 decreases expression ISO RGD:1315921 6480464 mirdametinib results in decreased expression of ERCC1 mRNA CTD PMID:21996734 PD 0325901 multiple interactions ISO RGD:1315921 6480464 mirdametinib inhibits the reaction [Cisplatin results in increased expression of ERCC1 mRNA], mirdametinib inhibits the reaction [Cisplatin results in increased expression of ERCC1 protein] CTD PMID:21996734 pemetrexed multiple interactions ISO RGD:1315921 6480464 Pemetrexed inhibits the reaction [resveratrol results in increased stability of and results in increased expression of ERCC1 mRNA], Pemetrexed inhibits the reaction [resveratrol results in increased stability of and results in increased expression of ERCC1 protein] CTD PMID:23912706 pemetrexed decreases expression ISO RGD:1315921 6480464 Pemetrexed results in decreased expression of ERCC1 mRNA, Pemetrexed results in decreased expression of ERCC1 protein CTD PMID:23912706 PhIP decreases expression ISO RGD:1315921 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of ERCC1 mRNA CTD PMID:22100608 pinosylvin increases expression ISO RGD:1315921 6480464 pinosylvin results in increased expression of ERCC1 mRNA CTD PMID:23333577 pirinixic acid multiple interactions ISO RGD:1315921 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ERCC1 mRNA CTD PMID:19710929 platinum affects response to substance ISO RGD:1315921 6480464 ERCC1 protein affects the susceptibility to Platinum CTD PMID:15788669 platinum(0) affects response to substance ISO RGD:1315921 6480464 ERCC1 protein affects the susceptibility to Platinum CTD PMID:15788669 prochloraz multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA CTD PMID:29038839 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of ERCC1 mRNA CTD PMID:22431067 quercetin increases expression ISO RGD:1315921 6480464 Quercetin results in increased expression of ERCC1 mRNA CTD PMID:21632981 quercitrin decreases expression ISO RGD:1315921 6480464 quercitrin results in decreased expression of ERCC1 mRNA CTD PMID:25193878 rac-lactic acid decreases expression ISO RGD:1315921 6480464 Lactic Acid results in decreased expression of ERCC1 mRNA CTD PMID:30851411 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of ERCC1 mRNA CTD PMID:33775663 resveratrol multiple interactions ISO RGD:1315921 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [resveratrol results in increased expression of ERCC1 mRNA] more ... CTD PMID:23912706 resveratrol affects response to substance ISO RGD:1315921 6480464 ERCC1 protein affects the susceptibility to resveratrol CTD PMID:23912706 SB 203580 increases expression ISO RGD:1315921 6480464 SB 203580 results in increased expression of ERCC1 mRNA CTD PMID:21165580 SB 203580 multiple interactions ISO RGD:1315921 6480464 SB 203580 inhibits the reaction [tanshinone results in decreased expression of ERCC1 mRNA] CTD PMID:21165580 SB 431542 multiple interactions ISO RGD:1315921 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERCC1 mRNA CTD PMID:27188386 sclareol multiple interactions ISO RGD:1315921 6480464 [sclareol co-treated with Cisplatin] results in decreased expression of ERCC1 protein CTD PMID:33164868 sclareol decreases expression ISO RGD:1315921 6480464 sclareol results in decreased expression of ERCC1 protein CTD PMID:33164868 selenium atom increases expression ISO RGD:1315921 6480464 Selenium results in increased expression of ERCC1 mRNA CTD PMID:19244175 sodium arsenate increases expression ISO RGD:1315922 6480464 sodium arsenate results in increased expression of ERCC1 mRNA CTD PMID:11353140 sodium arsenite multiple interactions ISO RGD:1315921 6480464 [sodium arsenite co-treated with Cisplatin] results in increased expression of ERCC1 protein CTD PMID:21696631 sodium arsenite increases expression ISO RGD:1315922 6480464 sodium arsenite results in increased expression of ERCC1 mRNA CTD PMID:11353140 sodium arsenite decreases expression ISO RGD:1315921 6480464 sodium arsenite results in decreased expression of ERCC1 mRNA, sodium arsenite results in decreased expression of ERCC1 protein CTD PMID:21776218 , PMID:29705342 sodium dichromate decreases expression ISO RGD:1315921 6480464 sodium bichromate results in decreased expression of ERCC1 mRNA CTD PMID:17685462 sterigmatocystin increases expression EXP 6480464 Sterigmatocystin results in increased expression of ERCC1 mRNA CTD PMID:34126181 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ERCC1 mRNA, Streptozocin results in increased expression of ERCC1 protein CTD PMID:22228707 streptozocin multiple interactions EXP 6480464 3-aminobenzamide inhibits the reaction [Streptozocin results in increased expression of ERCC1 mRNA], Curcumin inhibits the reaction [Streptozocin results in increased expression of ERCC1 mRNA] CTD PMID:22228707 sunitinib decreases expression ISO RGD:1315921 6480464 Sunitinib results in decreased expression of ERCC1 mRNA CTD PMID:31533062 Tanshinone I multiple interactions ISO RGD:1315921 6480464 SB 203580 inhibits the reaction [tanshinone results in decreased expression of ERCC1 mRNA] CTD PMID:21165580 Tanshinone I decreases expression ISO RGD:1315921 6480464 tanshinone results in decreased expression of ERCC1 mRNA CTD PMID:21165580 tetrachloromethane increases expression ISO RGD:1315922 6480464 Carbon Tetrachloride results in increased expression of ERCC1 mRNA CTD PMID:15056808 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ERCC1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ERCC1 mRNA CTD PMID:31150632 tetraphene increases expression ISO RGD:1315921 6480464 benz(a)anthracene results in increased expression of ERCC1 mRNA CTD PMID:22236718 theaflavin multiple interactions ISO RGD:1315922 6480464 [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9 more ... CTD PMID:23717041 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ERCC1 mRNA CTD PMID:34492290 trans-pinosylvin increases expression ISO RGD:1315921 6480464 pinosylvin results in increased expression of ERCC1 mRNA CTD PMID:23333577 trichostatin A multiple interactions ISO RGD:1315921 6480464 trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA], trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 protein] CTD PMID:22228707 trichostatin A decreases expression ISO RGD:1315921 6480464 trichostatin A results in decreased expression of ERCC1 mRNA, trichostatin A results in decreased expression of ERCC1 protein CTD PMID:22228707 triclosan affects expression ISO RGD:1315921 6480464 Triclosan affects the expression of ERCC1 mRNA CTD PMID:31714634 usnic acid multiple interactions ISO RGD:1315921 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of ERCC1 mRNA CTD PMID:22777745 valproic acid affects expression ISO RGD:1315922 6480464 Valproic Acid affects the expression of ERCC1 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1315921 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERCC1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1315921 6480464 Valproic Acid results in decreased expression of ERCC1 mRNA CTD PMID:26272509 valproic acid affects expression ISO RGD:1315921 6480464 Valproic Acid affects the expression of ERCC1 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:1315922 6480464 Vancomycin results in decreased expression of ERCC1 mRNA CTD PMID:18930951 veliparib multiple interactions ISO RGD:1315921 6480464 ERCC1 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]] CTD PMID:21227924 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ERCC1 mRNA CTD PMID:23034163 vitamin E increases expression ISO RGD:1315921 6480464 Vitamin E results in increased expression of ERCC1 mRNA CTD PMID:19244175 Y-27632 increases expression ISO RGD:1315921 6480464 Y 27632 results in increased expression of ERCC1 mRNA CTD PMID:20878077 zinc atom increases expression ISO RGD:1315921 6480464 Zinc results in increased expression of ERCC1 mRNA CTD PMID:15226459 zinc sulfate increases expression ISO RGD:1315921 6480464 Zinc Sulfate results in increased expression of ERCC1 mRNA CTD PMID:15226459 zinc(0) increases expression ISO RGD:1315921 6480464 Zinc results in increased expression of ERCC1 mRNA CTD PMID:15226459
